Search results
FTC targets 300 Big Pharma 'junk patents,' sends warning letters to top drugmakers
BenefitsPRO· 2 days ago"By filing bogus patent listings, pharma companies block competition and inflate the cost of...
Maine mom searches for answers to shortage of ADHD drugs
WCSH 6 Portland· 13 hours agoDemand for the drugs has increased dramatically since 2022 and the Food and Drug Administration...
3 Magnificent Stocks That Are Passive Income Machines
The Motley Fool via AOL· 3 days agoWhile AbbVie has been and will almost certainly continue to be a passive income machine, there's more to like about the stock than only its dividend. The company has perhaps ...
Cost and Viltepso: Financial assistance options, savings, more
Medical News Today· 3 days agoViltepso (viltolarsen) is a brand-name injectable solution that’s prescribed for certain people with...
Are Medical Stocks Lagging Entera Bio (ENTX) This Year?
Zacks via Yahoo Finance· 23 hours agoOn average, stocks in this group have lost 2.4% this year, meaning that ENTX is performing better in...
Cost and Valtoco: Financial assistance options, savings, more
Medical News Today· 3 days agoFor information about Valtoco, including Valtoco side effects, Valtoco dosage, and how to use the...
2 Instruments Stocks to Watch From a Prospering Industry
Zacks via Yahoo Finance· 3 days agoThe Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD) and Bruker (BRKR)...
Camzyos and cost: Reducing long-term drug costs and more
Medical News Today· 4 days agoThe cost of the drug with and without insurance can depend on several factors, such as whether...
2nd Circuit Clarifies When ‘Pay-for-Delay’ Deals Are Legal in Tossing Antitrust Claims | National...
Law.com· 3 days agoThe court, for its first time, clarified a 2013 U.S. Supreme Court ruling that such deals are...
Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
Morningstar· 3 days agoThe Company has also received notice of a new Paragraph IV certification...Norwich advising that it has submitted to the U.S. Food and Drug Administration ...
